BioNTech CEO confident Covid-19 vaccine will work on new UK variant

BioNTech's vaccine, developed together with US pharmaceutical company Pfizer, is authorised for use in more than 45 countries including Britain

German pharmaceutical company BioNTech is confident that its coronavirus vaccine works against the new UK variant, but further studies are need to be completely sure, its chief executive said Tuesday.
 

The variant, detected mainly in London and the southeast of England in recent weeks, has sparked concern worldwide because of signs that it may spread more easily. While there is no indication it causes more serious illness, numerous countries in Europe and beyond have restricted travel from the UK as a result.
 

“We don’t know at the moment if our vaccine is also able to provide protection against this new